Division of Nephrology, Hypertension & Transplantation, University of Florida, Gainesville, Florida, USA.
Department of Neurology, University of Chicago, Chicago, Illinois, USA.
Hemodial Int. 2021 Apr;25(2):188-197. doi: 10.1111/hdi.12912. Epub 2021 Feb 28.
Early initiation of maintenance hemodialysis has been associated with excess mortality in some studies, but the effects on cardiovascular (CV) mortality has not been studied. Moreover, whether the increased mortality is due to co-morbidities or early initiation of dialysis is unclear. We used a propensity score weighted analysis of the United States Renal Data System (USRDS) to examine how the estimated glomerular filtration rate (eGFR) at initiation of dialysis affects total and CV mortality.
Association between tertiles of eGFR at initiation of hemodialysis and all-cause and CV mortality were assessed in 676,196 adult patients who initiated hemodialysis between 2006 and 2014, using inverse probability of treatment weighting (IPTW) weighted multivariable regression models.
The intermediate (eGFR 8.7 to <13.0 mL/min) and early start groups (eGFR ≥13.0 mL/min) had a 42% and 93% increased all-cause mortality, respectively compared to late (eGFR < 8.7), start group (unadjusted hazard ratio (HR) = 1.42; 95% CI, 1.41-1.43 and HR = 1.93; 95%CI, 1.91-1.94, respectively). This association was attenuated but remained significant in propensity weighted multivariable analysis (adjusted HR = 1.13; 95%CI, 1.12-1.14 for intermediate and HR = 1.37; 95%CI, 1.36-1.39, for early start, respectively). The CV mortality was similarly increased (adjusted HR = 1.08; 95%CI, 1.07-1.10 and HR = 1.23; 95%CI, 1.21-1.24, for intermediate and early start, respectively). In patients with cystic kidney disease, all-cause mortality was increased with early start, but there were no differences in CV mortality between groups.
Early initiation of dialysis is associated with increased all-cause and CV mortality. Our observations support delaying hemodialysis according to the eGFR values.
一些研究表明,早期开始维持性血液透析与过高的死亡率相关,但尚未研究其对心血管(CV)死亡率的影响。此外,增加的死亡率是由于合并症还是早期开始透析尚不清楚。我们使用美国肾脏数据系统(USRDS)的倾向评分加权分析来检查透析开始时估算肾小球滤过率(eGFR)如何影响全因和 CV 死亡率。
在 2006 年至 2014 年间开始血液透析的 676196 名成年患者中,使用逆概率治疗加权(IPTW)加权多变量回归模型评估透析开始时 eGFR 的三分位数与全因和 CV 死亡率之间的关系。
与晚期(eGFR <8.7)开始组相比,中间(eGFR 8.7 至 <13.0 mL/min)和早期开始组的全因死亡率分别增加了 42%和 93%(未调整的危险比(HR)=1.42;95%CI,1.41-1.43 和 HR = 1.93;95%CI,1.91-1.94)。在倾向评分加权多变量分析中,这种关联虽然减弱但仍然显著(中间组调整后的 HR = 1.13;95%CI,1.12-1.14 和早期开始组 HR = 1.37;95%CI,1.36-1.39)。CV 死亡率也相应增加(调整后的 HR = 1.08;95%CI,1.07-1.10 和 HR = 1.23;95%CI,1.21-1.24,中间组和早期开始组分别)。在囊性肾病患者中,早期开始与全因死亡率增加相关,但各组之间 CV 死亡率无差异。
早期开始透析与全因和 CV 死亡率增加相关。我们的观察结果支持根据 eGFR 值延迟血液透析。